FDA Signs Off On Bayer's New Lung Cancer Drug — Early Results Look Promising

benzinga.com/news/health-care/25/11/48984253/fda-signs-off-on-bayers-new-lung-cancer-drug-early-results-look-promising

The Food and Drug Administration (FDA) on Wednesday granted accelerated approval to Bayer AG‘s (OTC:BAYRY) Hyrnuo (sevabertinib) for adults with a specific type of advanced lung cancer.
The approval covers locally advanced or metastatic, non-squamous non-small cell lung cancer whose…

This story appeared on benzinga.com, 2025-11-20 17:53:24.
The Entire Business World on a Single Page. Free to Use →